Correction: Outcomes in Patients with Acute Non-Q-Wave Myocardial Infarction Randomly Assigned to an Invasive as Compared with a Conservative Management Strategy.

Background Non–Q-wave myocardial infarction is usually managed according to an “invasive” strategy (i.e., one of routine coronary angiography followed by myocardial revascularization). Methods We randomly assigned 920 patients to either “invasive” management (462 patients) or “conservative” management, defined as medical therapy and noninvasive testing, with subsequent invasive management if indicated by the development of spontaneous or inducible ischemia (458 patients), within 72 hours of the onset of a non–Q-wave infarction. Death or nonfatal infarction made up the combined primary end point. Results During an average follow-up of 23 months, 152 events (80 deaths and 72 nonfatal infarctions) occurred in 138 patients who had been randomly assigned to the invasive strategy, and 139 events (59 deaths and 80 nonfatal infarctions) in 123 patients assigned to the conservative strategy (P=0.35). Patients assigned to the invasive strategy had worse clinical outcomes during the first year of follow-up. The numb...

[1]  J. Alpert,et al.  Non-Q wave myocardial infarction: recent changes in occurrence and prognosis--a community-wide perspective. , 1987, American heart journal.

[2]  H. Arendrup,et al.  Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). DANish trial in Acute Myocardial Infarction. , 1997, Circulation.

[3]  B. Sobel,et al.  Factors presaging early recurrent myocardial infarction ("extension"). , 1981, The American journal of cardiology.

[4]  L. Cohn,et al.  ACC/AHA guidelines for cardiac catheterization and cardiac catheterization laboratories. American College of Cardiology/American Heart Association Ad Hoc Task Force on Cardiac Catheterization. , 1991, Circulation.

[5]  S. Pocock,et al.  Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. , 1975, Biometrics.

[6]  E. Gilpin,et al.  Prognosis after extension of myocardial infarct: the role of Q wave or non-Q wave infarction. , 1985, Circulation.

[7]  L. Klein,et al.  The Q-wave and non-Q wave myocardial infarction: differences and similarities. , 1986, Progress in cardiovascular diseases.

[8]  H. Krumholz Cardiac procedures, outcomes, and accountability. , 1997, The New England journal of medicine.

[9]  M. Gheorghiade,et al.  Acute non-Q wave myocardial infarction associated with early ST segment elevation: evidence for spontaneous coronary reperfusion and implications for thrombolytic trials. , 1987, Journal of the American College of Cardiology.

[10]  J. Miller,et al.  Electrocardiographic subset analysis of diltiazem administration on long-term outcome after acute myocardial infarction. The Multicenter Diltiazem Post-Infarction Trial Research Group. , 1991, The American journal of cardiology.

[11]  J. Magovern,et al.  A model that predicts morbidity and mortality after coronary artery bypass graft surgery. , 1996, Journal of the American College of Cardiology.

[12]  Gibson Rs Non-Q-wave myocardial infarction: diagnosis, prognosis, and management. , 1988 .

[13]  K. Lee,et al.  A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. , 1987, The New England journal of medicine.

[14]  W. Boden Management of Non‐Q‐Wave Myocardial Infarction: Role of Diltiazem Versus β‐Blocker Therapy , 1990, Journal of cardiovascular pharmacology.

[15]  G. Lamas,et al.  A comparison of management patterns after acute myocardial infarction in Canada and the United States. The SAVE investigators. , 1993, The New England journal of medicine.

[16]  M. Chung,et al.  Is age an independent predictor of early and late mortality in patients with acute myocardial infarction? , 1992, The American journal of medicine.

[17]  L. Klein,et al.  The non-Q wave myocardial infarction revisited: 10 years later. , 1997, Progress in cardiovascular diseases.

[18]  Richard P. Lewis,et al.  ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.

[19]  R. Kleiger,et al.  Electrocardiographic and enzymatic findings in acute non-Q wave myocardial infarction: results from the multicenter diltiazem reinfarction study , 1988 .

[20]  E. Braunwald,et al.  Predictors of non-Q-wave acute myocardial infarction in patients with acute ischemic syndromes: an analysis from the Thrombolysis in Myocardial Ischemia (TIMI) III trials. , 1995, The American journal of cardiology.

[21]  D. Waters,et al.  PATHOPHYSIOLOGY AND NATURAL HISTORY , 2005 .

[22]  C D Naylor,et al.  Assessing the outcomes of coronary artery bypass graft surgery: how many risk factors are enough? Steering Committee of the Cardiac Care Network of Ontario. , 1997, Journal of the American College of Cardiology.

[23]  J. W. Kennedy,et al.  Non-Q-wave myocardial infarction. , 1986, Lancet.

[24]  R. Kleiger,et al.  Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial. , 1986, The New England journal of medicine.

[25]  E. Gilpin,et al.  Short- and long-term clinical outcome after Q wave and non-Q wave myocardial infarction in a large patient population. , 1989, Circulation.

[26]  R. Kleiger,et al.  Electrocardiographic evolution of posterior acute myocardial infarction: importance of early precordial ST-segment depression. , 1987, The American journal of cardiology.

[27]  P. O'Brien,et al.  A multiple testing procedure for clinical trials. , 1979, Biometrics.

[28]  R. Kleiger,et al.  Differential risk patterns associated with 3 month as compared with 3 to 12 month mortality and reinfarction after non-Q wave myocardial infarction. The Diltiazem Reinfarction Study Group. , 1990, Journal of the American College of Cardiology.

[29]  E L Hannan,et al.  Identification of preoperative variables needed for risk adjustment of short-term mortality after coronary artery bypass graft surgery. The Working Group Panel on the Cooperative CABG Database Project. , 1996, Journal of the American College of Cardiology.

[30]  F H Edwards,et al.  Coronary artery bypass grafting: the Society of Thoracic Surgeons National Database experience. , 1994, The Annals of thoracic surgery.

[31]  J. Fleiss,et al.  Risk stratification and survival after myocardial infarction. , 1983, The New England journal of medicine.

[32]  L. Wilkins Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. , 1994, Circulation.

[33]  R. Kleiger,et al.  Frequency and significance of late evolution of Q waves in patients with initial non-Q-wave acute myocardial infarction☆ , 1990 .

[34]  David J. Feild Guidelines for coronary angiography: A report of the American College of Cardiology/American Heart Association task force on assessment of diagnostic and therapeutic cardiovascular procedures (Subcommittee on coronary angiography) , 1987 .